The Netherlands is investing in cellular agriculture by establishing two new facilities to help food companies scale cell culture and precision fermentation. These open-access plants will enable F&B players in the sector to enhance R&D capabilities without spending on costly, pilot-scale production infrastructure. “By 2025, we anticipate more companies submitting regulatory approval dossiers and moving closer to cost-effective production. Offering open-access upscaling facilities will allow companies to progress faster and more cost-efficiently by not having to invest in pilot facilities themselves,” Marcel Oogink, MD of one of the facilities, Biotechnology Fermentation Factory (BFF), tells Food Ingredients First.
